Boehringer Ingelheim expands Fremont biologics facility with $217M
Boehringer Ingelheim broke ground on a $217 million expansion of its Fremont, California manufacturing facility. The expansion will triple capacity and add nearly 300 new jobs.
Capacity
increase manufacturing capacity by one-third
Productshuman biologics medicines
“This significant expansion will enable the company to increase its manufacturing capacity by one-third”prnewswire.com
- 3 sources
- prnewswire.comBoehringer Ingelheim Breaks Ground on $217 Million Expansion of Fremont, California Manufacturing FacilityBoehringer IngelheimJul 21, 2017
- biopharmadive.comBoehringer to invest $217M in manufacturing build-out at CA site | BioPharma DiveSuzanne ElvidgeJul 26, 2017
- pharmaceutical-technology.comBoehringer Ingelheim Manufacturing Facility Expansion, FremontPraveenNov 13, 2017
Summarized from public sources; check the original articles before acting on it.
ENDATA